‌

US Patent 11491129 Oral formulations of bipolar trans carotenoids

Patent 11491129 was granted and assigned to Diffusion Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Diffusion Pharmaceuticals

Current Assignee

Diffusion Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 8, 2022

Patent Application Number

16030496

Date Filed

July 9, 2018

Patent Citations

US Patent 11147859 Diffusion enhancing compounds and their use alone or with thrombolytics

US Patent 10016384 Oral formulations of bipolar trans carotenoids

US Patent 10130689 Diffusion enhancing compounds and their use alone or with thrombolytics

US Patent 11185523 Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer

Patent Primary Examiner

David J Blanchard

The subject invention relates to a variety of formulations of bipolar trans carotenoids including pharmaceutical compositions for oral delivery of a bipolar trans carotenoid comprising i) a bipolar trans carotenoid, ii) a cyclodextrin, and iii) a coating. The invention also relates to preparation of such formulations and their uses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11491129 Oral formulations of bipolar trans carotenoids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.